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Background: Different polymorphisms have been described as markers to classify the lineages of the Mycobacterium
tuberculosis complex. The analysis of nine single nucleotide polymorphisms (SNPs) was used to describe seven SNPs
cluster groups (SCGs). We attempted to classify those strains that could not been categorized into lineages by the
genotyping methods used in the routine testing.
Results: The M. tuberculosis complex isolates collected in 2010 in our region were analysed. A new method based on
multiplex-PCRs and pyrosequencing to analyse these SNPs was designed. For the pyrosequencing assay nine SNPs that
defined the seven SCGs were selected from the literature: 1977, 74092, 105139, 232574, 311613, 913274, 2460626,
3352929 and gyrA95. In addition, SNPs in katG463, mgtC182, Ag85C103 and RDRio deletion were detected.
Conclusions: This work has permitted to achieve a better classification of Aragonian strains into SCGs and in some
cases, to assign strains to its certain lineage. Besides, the description of a new pattern shared by two isolates “SCG-6c”
reinforces the interest of SNPs to follow the evolution of M. tuberculosis complex.
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The species of the Mycobacterium tuberculosis complex
(MTC) show a 99.9% of similarity in their nucleotide
sequence and their 16SrRNA do not differ between
members, only M. canetti does [1]. Despite this identity
in their genomes, a large number of long sequence poly-
morphisms (LSPs), a variation in repetitive elements
in the genome, and single nucleotide polymorphisms
(SNPs) have been detected [2,3]. It is the diversity of
such polymorphisms, which is taken for phylogenetic
studies with clinical isolates. In 1997, Sreevatsan et al.
based on the presence of two SNPs in gyrA95(AGC→ACC)
and katG463(CGC→CTG), classified all MTC isolates into
three principal genetic groups or PGGs [4]. Afterwards,* Correspondence: ssamper.iacs@aragon.es
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reproduction in any medium, provided the orBrudey et al. based on the “Direct Repeat” locus (DR) di-
versity detected by Spoligotyping, classified thousands of
MTC clinical strains isolated worldwide in different line-
ages or families [5]. These families were named according
with their main geographical origin; Latin American-
Mediterranean family (LAM) isolates, which are the cause
of 15% of the new TB (tuberculosis) cases detected each
year worldwide, are highly prevalent in Latin America and
the Mediterranean area [6,7]. Within this family a sub-
lineage has been characterized by a genomic deletion
known as RDRio, which was firstly detected in Brazil, but
it was widely spread throughout the world [8,9]. Haarlem
family is ubiquitous throughout the world and accounts
for 25% of the isolates extracted in Europe, Central
America and the Caribbean [10]. The T family is an “ill
defined” family that was characterized by default. It in-
cludes over 600 shared international types (SITs) and it
has been divided into 5 subgroups, from T1 to T5 [5,7].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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multidrug-resistant (MDR) outbreaks identified [11]. S
family was identified predominantly in patients of
Italian origin [7]. “X” family was described to be highly
prevalent in North America (21.5%) and Central America
(11.9%), although some researchers correlate it with
African-Americans [5]. Central Asian family (CAS) has
been identified mostly in India, where presents a com-
mon sub-lineage called CAS-1 [7]. East African Indonesian
family (EAI) has a higher prevalence in Southeast Asia,
particularly in The Philippines, Malaysia, Vietnam and
Thailand [12,13]. Finally, the U family (Undefined) does
not meet the criteria of the other described families and it
is considered separately [5]. Furthermore, a set of SNPs
has been published as markers with phylogenetic value.
Thus, seven phylogenetically different SNP cluster groups
(SCGs) with 5 subgroups have been defined based on a set
of SNPs, which have been related to the previously defined
families [14-16]. Other significant polymorphisms were
described as markers for particular families. By way of illus-
tration, SNP in Ag85C103(GAG→GAA) has been associated
with LAM family strains [8] and among these strains a
genomic deletion known as RDRio has been defined [9].
Likewise, some specific polymorphisms in ogt44(ACC→AGC),
ung501501(CTG→CTA) and mgtC182(CGC→CAC) could serve as
genetic markers for Haarlem family [17,18]. Finally, a
global phylogeny for M. tuberculosis was described
based on LSPs by six phylogeographical lineages, besides
the M. bovis and M. canetti branches [19], showing the
prevalence of one of the lineages in Europe and America,
the Euro-American lineage, which regroups the strains that
had generally been described as principal genetic groups
(PGG) 2 and 3 [19].
Since 2004 the genotyping of all clinical isolates of
M. tuberculosis complex by IS6110-based restriction
fragment length polymorphism (RFLP) and Spoligotyping
in Aragon is systematically performed. Aragon is a region
in the Northeast of Spain with 1,345,419 registered in-
habitants in the studied year 2010 (http://www.ine.es/
jaxi/tabla.do).
The aim of this study was to classify our collection of
isolates into SCG lineages, especially those belonging to
“U”, “ill-defined” T families and isolates with no family
associated. With this intention, we have designed a method
based on SNPs detection by multiplex-PCR and pyrose-
quencing [16,20].
Methods
Sample selection
A total of 173 clinical isolates of M. tuberculosis complex
collected as part of standard patient care from different
areas within Aragon in 2010 had been previously identified,
susceptibility to first line drugs tested and genotyped by
using IS6110-RFLP and Spoligotyping techniques. Theseisolates had been assigned to a lineage or family after have
been compared their spoligopatterns with those of the
SpolDB4 (fourth international spoligotyping database) [5],
in the context of the Surveillance Network monitoring the
potential transmission of tuberculosis in Aragon. For the
SCG determination assay 101 out of 173 were selected ac-
cording to the following conditions: only one sample for
each RFLP-IS6110 cluster and the samples with a unique
RFLP. Once we confirmed that the isolates with the same
spoligopattern were included in the same SCG, a sample
selection was made by choosing one isolate for each spoli-
gopattern, resulting in 75 different isolates for further
analysis (Table 1). Reference strain H37Rv was included as
a control in each test performed.
The analysis of the DR Region was done in one case in
which no positive hybridisation was obtained by spoligo-
typing using primers DR22-R (5′-AGACGGCACGAT
TGAGAC) and DR43-F (5′-ACCCGGTGCGATTCTG
CG). As no amplification was obtained a deletion of the
region in this strain was considered and remains under
study. This isolate was considered in the study among
the no SIT assigned.
Analysis of PGGs and SCGs and specific lineage
polymorphisms
For the pyrosequencing assay nine SNPs that defined
the seven SCGs, were selected from the literature
[15]: g.1977A > G, g.74092C > T, g.105139C > A, g.23
2574G >T, g.311613G >T, g.913274C >G, g.2460626C >A,
g.3352929C >G, and gyrA95G→C (Table 2). The SNPs pre-
sented in mgtC182(CGC→CAC), in katG463(CGC→CTG) and in
Ag85C103(GAG→GAA) were identified by sequencing or PCR-
RFLP as previously described [8,17,21]. RDRio deletion was
detected by performing a multiplex-PCR [9]. The pattern
obtained for the gyrA95 and katG463 polymorphisms was
coupled to classify each isolate into the different PGGs.
Pyrosequencing analysis designed for SNP detection
Four multiplex PCR and one simplex PCR were devel-
oped to analyse the presence of the nine SNPs within
our strains (Figure 1). The SNPs location and gene se-
quence in H37Rv genome were downloaded from the
Tuberculist website (http://tuberculist.epfl.ch/). Primers
were designed using the Qiagen® PSQ Assay Design v2.0
software. The programme provided the most suitable
primers for DNA amplification, labelling and pyrose-
quencing, as well as the optimal primer combination in
multiplex PCRs (Table 3). For pyrosequencing, an indir-
ect labelling protocol adapted from the literature was
followed [20]. First, the PCRs were performed using a
universal biotinylated M13 primer and the specific couple
of primers (forward and reverse) for each SNP. In a second
step, we used the PCR products to pyrosequence them
with the subsequent sequencing primer. Each PCR mix
Table 1 Description of the 173 isolates of 2010 in Aragon analysed in this study
Family based on SpolDB4 Isolates genotyped by IS6110-RFLP
and spoligotyping (N = 173)
Isolates studied by SNPs and
classified on SCG (N = 101)
Isolates selected based on their
different spoligotypes (N = 75)
AFRICANUM AFRI_1 1 1 (0.57%) 1 1 (0.99%) 1 1 (1.33%)
BEIJING BEIJING 1 1 (0.57%) 1 1 (0.99%) 1 1 (1.33%)
BOVIS
BOVIS1 1
3 (1.7%)
1
3 (2.97%)
1
2 (2.66%)BOVIS1_BCG 2 2 1
CAS CAS 2 2 (1.25%) 1 1 (0.99%) 1 1 (1.33%)
EAI EAI7_BGD2 1 1 (0.57%) 1 1 (0.99%) 1 1 (1.33%)
HAARLEM
H1 15
41 (23.6%)
7
25 (24.75%)
6
15 (20%)
H2 6 2 1
H3 19 15 7
H3-T3 1 1 1
LAM
LAM1 1
24 (13.8%)
1
17 (16.83%)
1
10 (13.33%)
LAM10_CAM 2 1 1
LAM12_MAD1 2 1 1
LAM2 2 2 1
LAM3 5 5 1
LAM9 12 7 5
S S 4 4 (2.31%) 3 3 (2.97%) 2 2 (2.66%)
X
X1 3
5 (1.15%)
1
2 (1.98%)
1
2 (2.66%)X2 2 1 1
T
T1 27
34 (19.6%)
12
16 (15.84%)
9
13 (17.33%)
T2 2 1 1
T4_CEU1 2 1 1
T5 1 1 1
T5_MAD2 2 1 1
U
U 24
26 (15.0%)
10
12 (11.88%)
7
9 (12.00%)U (LAM3?) 2 2 2
No family NO SIT 31 31 (17.9%) 19 19 (18.81%) 18 18 (24.00%)
Table 2 Base detected at SNPs by pyrosequencing, SCGs and PGGs
Base at SNP site
1977 74092 105139 232574 311613 913274 2460626 3352929 gyrA95 PGG SCG
G C A G T C C G C 1 2
G C C G T C C G C 1 3a
G C C G T C C G C 2 3b
G C C T T C Ca Ga C 2 3c
G C C T T C Aa Ga C 2 4
G C C G T C C C C 2 5
A C C G T C C C G 3 6a
A C C G G C C C G 3 6b
G T C G T G C G C 1 7
G C C G T G C G C 1 1
A C C G T C C G G 3 6c*
Table adapted from Bouakaze and co-workers [15] and ainferred from Filliol and coworkers [16]. *New pattern SCG-6c.
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Figure 1 Pyrograms obtained for different sample assays. Pyrograms of possible SNP combinations and interpretation for each of the 4
mixed reactions and for the single reactions for detect the gyrA polymorphism are shown.
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0.01% Tween-20, 1,5 mM MgCl2, 200 μM dNTP’, 0.5U Su-
perHot Taq (Bioron®), 10 pmol of the biotinylated universal
M13 primer (5 pmol for GyrA95 PCR mix), 1 μl of each
couple of primers (except for 311613-M13:1.3 μl; 232574-
M13: 1.5 μl, 913274-M13:1.5 μl) and 1 μl of DNA sample
and was adjusted to a final volume of 25 μl with HPLC
water. Primers that were not being labelled with biotin in
the PCR and the universal M13 primer were used at a con-
centration of 5 pmol/μl; 25 fmol/μl was used for thosehaving the M13 tail. A 10 pmol/μl concentration was
employed for all sequence primers. Amplification was
performed in a Veriti® 96-Well Thermal Cycler (Applied
Biosystems) for 2 min at 94°C followed by 40 cycles of
15 sec at 94°C, 30 sec at 64°C and 30 sec at 72°C. The amp-
lified products were visualized in a 1.8% agarose gel and
were loaded together with a 100 bp molecular weight
marker (Bioron®). In PCR plates of 96 wells we mixed 40 μl
of binding buffer (Qiagen®) and 3 μl of streptavidin-coated
Sepharose (GE-Healthcare®) beads to the 25 μl of PCR
Table 3 SNP location, primers and PCR designed for pyrosequencing analysis
PCR primer sequence (5′→ 3′)
Geneª SNP locationª PCRb Amplicon (bp)b Forwardb Reverseb
dnaA:dnaN 1977
Multiplex 1
131 [M13] - TGAGAAGCTCTACGGTTGTT
GTTCG
TTTCACCTCACGATGAGTTCGATCC
(Rv0001:Rv0002)
Rv0260c 311613 114 CACCACTGTTGCCACGATGTTCTT [M13] - GGCGACTTGCTACGCGTCCTAC
icd2 (Rv0066c) 74092
Multiplex 2
88 [M13] - GACGGTCCGAATTGCCTTGG GACCAGGAGAAGGCCATCAAAGAG
phoT (Rv0820) 913274 141 GCAATCGCCGTGCAACC [M13] - CTGCATGTTATGGGTGACGATGAC
Rv0095c 105139
Multiplex 3
94 ATAACGTCGGGCACTGACAAAGAG [M13]-TCCCGTATCAACTCGTAGGATCTGG
Rv0197 232574 81 CCACGGCGGGGACAAGAT [M13] -AGAAAGGCGCCGCTGTAGG
qcrB (Rv2196) 2460626
Multiplex 4
120 [M13] - GGGCTCGCAGCCAGACTTC ATGATCACGGCGACCCAGAC
leuB (Rv2995c) 3352929 108 [M13] - TCGACGTCCGGGTAGCATTC GCGTCGCAAGCATCTGACATT
gyrA (Rv0006) codon 95 Simplex 320 CAGCTACATCGACTATGCGA [M13] - GGGCTTCGGTGTACCTCAT
Universal primer
[M13]: CGCCAGGGTTTTCCCAGTCACGAC
aGene name and SNP location in M. tuberculosis H37Rv genome map (http://tuberculist.epfl.ch/). One gene is listed when SNP location is situated in that gene and
two genes are listed when SNP is intergenic.
bPCR name, amplicon expected size, and primers used.
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30 min at 1,400 r.p.m. in an Eppendorf Thermomixer®.
Using the Vacuum Prep Tool the biotinylated PCR prod-
ucts were picked up with the 96-filter-unit and conse-
quently immobilized on the streptavidin-coated Sepharose
beads. Then, the non-biotinylated DNA was removed by
placing the filter unit in the denaturation solution for 5 s,
thus generating ssDNA for pyrosequencing. After neutral-
isation, the vacuum was switched off and the beads con-
taining the PCR product were transferred to a 96-well
plate with 16 pmol of each sequencing primer in 40 μl an-
nealing buffer (Qiagen®). The sample was transferred into a
reaction plate (PSQ 96 Plate Low, Qiagen ®) and incubated
for 2 min at 80°C. The volume of enzymes, substrate
and nucleotides calculated by PyroMark Q96 ID soft-
ware was added to the PSQ 96 Cartridge accordingly.
Pyrosequencing and SNP analysis were done using the
PSQ™96MA System and its software (Qiagen®).
Results
We analysed the MTC strain family distribution of 173
isolates collected in 2010 from across Aragon (Table 1).
Within this set and according with the spoligotyping
analysis, the Haarlem genotype was the most frequent
genotype (23.6%), followed by the T “ill defined” family
(19.6%), U (15%) and LAM (13.8%). Other genotypes
showing a defined SIT (9.8%) grouped in smaller groups.
Those isolates showing a pattern with no SIT assigned in
the spolDB4 database corresponded to 17.9%. Among
the 173 isolates, 91 isolates were included in the T, U
and no SIT groups representing the 52.6% of the isolates.
Accepting those with the same RFLP-IS6110 genotype as
clone-related isolates and therefore belonging to thesame family or lineage, only one isolate of each RFLP-
IS6110 genotype, 101 isolates, were analysed by pyrose-
quencing (Figure 1). Once tested for the presence of the
nine SNPs, we could confirm that those isolates with the
same spoligopattern held into the same SCG. For further
analysis one isolate for each spoligopattern was selected
resulting a sample of 75 different MTC strains.
Seven of the 75 strains according with their SNPs in
gyrA and katG genes were found to belong to PGG-1, 52
were included in PGG-2 and 16 were grouped in PGG-3.
The strains in PGG-1 shared the SNPs for SCG-7, SCG-
1, SCG-2 and SCG-3a. The SCG-3b, SCG-3c and SCG-5
met the feature for PGG-2. Finally, PGG-3 embraced the
isolates in SCG-6a and a new SCG that from now on it
will be mentioned as “SCG-6c”. The described SCG-6b
pattern was only observed for the isolate of H37Rv used
as a control. The distribution of these results is drawn
and shown in Figure 2 and Table 4. The vast majority of
the strains (64 of the 75) were classified in 3 SCGs:
SCG-3b, SCG-5 and SCG-6a, in order of relevance. It
should be noted that isolates in SCG-4 and SCG-6b were
not represented in this study.
Regarding the spoligo-families detected (Figure 3), the
unique isolates in our study belonging to AFRI_1 and
EAI7_BGD2 families were grouped in SCG-1. The Beijing
strain corresponded to the SCG-2 and the unique CAS
isolate was included in SCG-3a. The M. bovis-BCG and
M. bovis isolates (for one of them the SIT was not
assigned) were grouped into SCG-7. The fifteen cases
known to belong to the Haarlem family were grouped in
SCG-3b. The 10 LAM and also the two S family strains
were classified in SCG-5. Two cases belonging to the X
family were included in SCG-3c. Our results showed that
Figure 2 Dendrogram based on the spoligotypes of the M. tuberculosis complex strains studied. SIT–shared international type, SCG and
PGG are detailed. In one isolate a deletion was detected in the DR locus reflected in a negative spoligotype results.
Table 4 Classification of the 75 clinical isolates analyzed
according to PGG and SCG
SCG 1 2 3a 3b 3c 5 6a 6b 6c** 7 Total
PGG 1 2 1 1 3 7
PGG 2 27 2 23 52
PGG 3 14 * 2 16
75
*Reference strain H37Rv. **New SCG subgroup reported.
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ill-defined T, U family or with no SIT assigned, were
distributed among SCG-3b, SCG-7, SCG-5, SCG6-a and
SCG-6c (Table 5).
SCG-3b included twelve isolates, nine of them were
not assigned to any of the spoligo-families, one isolate
belonged to T1 family (SIT 1129), one isolate to T4_CEU1
family (SIT 39) and one isolate to U family (SIT 232). Fur-
thermore, additional SNP at codon 182 in mgtC gene spe-
cific to the Haarlem family was studied in these strains.
The codon mgtC182(CAG) was present in eight of these iso-
lates, including the classified as SIT 232.
Figure 3 Phylogenetic tree based on the 9 SNPs selected for
SCGs. Model-based neighbour-joining tree based on the 9 SNPs
resolved of the 75M. tuberculosis complex isolates and the reference
strain analysed into the different SCGs. Numbers designate each
SCG and Spoligotyping families are indicated by a different colour
detailed in the legend. The SNP lineages that belong to the three
“major genetic” groups based on combination of two alleles at
katG463 and gyrA95 are also highlighted. The scale bar indicates
the number of SNP difference.
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1567), U (SIT 132, 402 and 1241) and U-LAM3 (SIT 105
and 106) families and four isolates which did not have any
SIT assigned. They were studied to settle on their LAM
family membership. All of them except two (SIT 284 and
other with no SIT assigned) presented the LAM specific
SNP in Ag85C103(GAG→GAA). In addition, we found that
two among the isolates tested, or five considering all the
LAM strains, contained the RDRio deletion, which is a fea-
ture of a subgroup of the LAM family strains.
SCG-6a included a total of 14 isolates, which belonged
to T1 (SIT 53, 154, 167, 358, 1122), T2 (SIT 52), T5
(SIT 44), T5_MAD2 (SIT 58), U (SIT 602 and 773)
and 4 isolates with not SIT assigned. None of them hadTable 5 Phylogenetic distribution of the T, U and with no SIT
SCG Family T
T1 T2 T4-CEU1 T5
3b Haarlem
No Haarlem 1 1
7 BOVIS
5 LAM 1
No LAM 1
6a “Authentic” T 5 1 1
6c New pattern 1
Total 9 1 1 1either the SNP in Ag85C103 or the SNP in mgtC182. This
SCG-6a included the isolate of the most representative
cluster in 2010, ARA7 (SIT 773, U family), which gathered
133 clinical cases since 2004 [22]. Finally, two unrelated
and different isolates presented the same new pattern
named SCG-6c, which only differs from SCG-6a in one
SNP (Table 2). The first isolate (SIT 90, U) was related
with the outbreak ARA21 (20 cases collected since 2004)
and the second isolate (SIT 120, T1 family) had not been
previously reported in our Region. Neither contained the
SNP in Ag85C103 nor the SNP in mgtC182 feature for
LAM or Haarlem families respectively.
Discussion
The Euro-American lineage was found to be the predom-
inant lineage of the M. tuberculosis complex in Europe
[19]. The MDR TB studies carried out in Spain showed the
Euro-American as the more prevalent lineage [23], and
that a few LAM and Haarlem strains, which belong to this
lineage, played a major role in the spread of MDR strains
[24]. According to this, the 90% of the tuberculosis strains
analysed in this work belong to this lineage. Our work
allowed to classify a collection of MTC strains previously
analysed by Spoligotyping and RFLP in Aragon in lineages
as well as in SCGs by the detection of the 9 SNPs that de-
fine the 7 SCGs [15,16] together with PCR identification of
katG463, Ag85C103 and mgtC182 polymorphisms. All these
single polymorphisms as a whole have proved to be an ef-
fective complement for both Spoligotyping and RFLP tech-
niques that enhance their sensibility, especially in those
families identified at the beginning as T, U and orphan. A
notorious circumstance to remark in our population was
that the two largest clusters of M. tuberculosis strains,
named ARA21 and ARA7, belonged to T and unclassified
groups of families. Besides, ARA7 had caused an outbreak
since 2004, what resulted in around the 20% of cases of tu-
berculosis [22]. This fact allows the classification of these
strains into more resolved families. In addition, the 9 SNPs
detection by using a pyrosequencing assay leads to obtain
quick and reliable results at an affordable cost [20].isolates according to their SCG
U No SIT Total
T5-MAD2 U U (LAM3)
1 7 8
2 4
1 1
3 2 3 9
1 2
1 2 4 14
1 2
1 7 2 18 40
Cabal et al. BMC Microbiology 2014, 14:21 Page 8 of 9
http://www.biomedcentral.com/1471-2180/14/21We have shown that some strains identified by Spoli-
gotyping as T, U or even orphan, which represent in our
study the 52.6% of the isolates, belong in fact to defined
families that could be assigned by using the aforemen-
tioned polymorphism set. In few occasions it was not
possible to group those strains into a family with cer-
tainty, therefore SNP detection in Ag85C103 and
mgtC182 was needed. Thus, regarding SCG-3b, the most
prevalent in our community, the addition of a specific
SNP detection as mgtC182, a characteristic SNP of the
Haarlem family, gave more specific information. Filliol
and collaborators joined in this SCG-3b basically Haarlem
isolates, but also some T, LAM, and orphan strains [16].
It either happened the same concerning SCG-5, the sec-
ond most prevalent SCG in Aragon, in which Filliol and
collaborators included essentially LAM strains, but also
T, Haarlem, S, unknown and orphan isolates [16]. The
pyrosequencing method applied allows to include an iso-
late in SCG-5, further the Ag85C103 asserts of its LAM
membership even if spoligotyping had not been detected
it at first. Regarding SCG-6a, which was the third group
of relevance in our study, we believe it includes the vast
majority of the T isolates that would group as the
“authentic T” isolates, being a more evolved strains since
they belong to the PGG-3. Another achievement of this
SNPs set has been the discovery of the two genetically
and epidemiologically not linked isolates included in the
new “SCG-6c”. It suggests that the tubercle bacillus is
incessantly varying and highlights the value of SNPs to
follow the evolution of M. tuberculosis complex.
Concerning the PGG determination, around 70% of
the strains circulating in our community grouped in the
PGG-2. This study provides a first inside into the struc-
ture of the M. tuberculosis population in Aragon and
Spain. The strains causing the largest clusters were clas-
sified as belonged to PGG-3, ARA7 (SCG-6a) and
ARA21 (SCG-6c), what means these modern strains are
causing the more cases of TB in our region, both of them
belong to the Euro-American lineage [19,25]. Comparing
our results with a study carried out in London [26], we
appreciate less diversity regarding Spoligo-families prob-
ably due to the minor rate of patients that born abroad in
respect to the London population. They characterised the
MTBC strains using SNPs, however some of the isolates
remained unclassified. A recent publication designed an
algorithmic differentiating Euro-American based on poly-
morphic SNPs in 5 genes in an extend collection of well-
classified members of the MTB complex [27]. However,
the application of the analysis of the set of SNPs previ-
ously described [8,17,21] selected in this study allowed us
to assign 75 strains sharing different spoligotypes to dif-
ferent SCGs and families in the MTC, specially those
assigned to the ill defined T and other unclassified. We
believe that classifying our isolates in the precedentPGGs previously described along with the SCGs and
spoligo-families provided the appropriate information to
better understand the phylogenetic background of the
Aragonian strains being this approach applicable to other
isolates of any geographical location.
Conclusions
In conclusion, the current study shows that the poly-
morphisms selected have been quite useful to comple-
ment and enrich the characterization of all isolates,
specifically for those that would not have been classified
by other routine techniques. Although more studies with a
larger amount of samples would be required, this work
has allowed us to do a better classification of Aragonian
strains into SCGs and PGGs by using pyrosequencing and
conventional PCR, and in some cases, to assign strains to
a certain lineage. Besides, the description of a new pattern
shared by two isolates “SCG-6c” reinforces the interest of
SNPs to follow the evolution of M. tuberculosis complex.
In addition, our work describes the successful develop-
ment of a multiplex-PCR and pyrosequencing assay based
on SNP detection as a purpose to classify M. tuberculosis
isolates into more resolved phylogenetic groups called
SCGs and to determine the principal genetic groups.
Therefore we suggest the use of this pyrosequencing tech-
nique as a complement to current phylogenetic and epi-
demiological investigations.
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